Treatment for Persistent Wheezing After Community-Acquired Pneumonia in Children
Evaluation and Diagnosis
- Persistent wheezing for 3 weeks after community-acquired pneumonia suggests possible post-infectious reactive airway disease or underlying asthma triggered by the pneumonia 1, 2
- Children with perihilar and bilateral pulmonary infiltrates accompanied by wheezing may have infection with Mycoplasma or Chlamydia pneumoniae 1
- For children with initially confirmed viral community-acquired pneumonia who develop secondary bacterial infection, further investigation for bacterial pathogens is warranted if clinical deterioration is supported by laboratory evidence of increased inflammation 1
Treatment Algorithm
- Determine if the wheezing is associated with respiratory distress, increased work of breathing, or oxygen desaturation 3, 4
- Consider whether the wheezing is due to ongoing infection with atypical pathogens 1
- For wheezing with moderate respiratory symptoms, consider short-course inhaled corticosteroids 4
- Add a short-acting beta-agonist as needed for symptom relief 4
Management and Follow-up
- If wheezing is severe or associated with respiratory distress, consider a short course of oral corticosteroids 1
- If suspecting atypical pathogens, consider testing for Mycoplasma or Chlamydia pneumoniae 1
- If testing will take several days, empiric therapy with a macrolide may be warranted 1
- The child should be reviewed if symptoms are deteriorating or not improving after 48 hours on treatment 4
- Provide education to parents about managing symptoms and identifying signs of deterioration 4
Special Considerations
- Avoid unnecessary antibiotics if the wheezing appears to be post-infectious reactive airway disease rather than ongoing bacterial infection 4, 6
- If the child shows signs of respiratory failure or significant respiratory distress, immediate referral to a higher level of care is necessary 1
- For children with non-responding community-acquired pneumonia, consider further investigation to identify whether the original pathogen persists, has developed resistance, or if there is a new secondary infection 7